As of 2025-06-21, the Relative Valuation of Sino Biopharmaceutical Ltd (1177.HK) is 3.55 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 4.99 HKD, the upside of Sino Biopharmaceutical Ltd based on Relative Valuation is -28.8%.
The range of the Relative Valuation is 2.59 - 4.29 HKD.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 12.5x | 11.0x |
| Forward P/E multiples | 10.7x - 12.0x | 11.8x |
| Fair Price | 2.59 - 4.29 | 3.55 |
| Upside | -48.1% - -14.1% | -28.8% |
| Date | P/E |
| 2025-06-16 | 158.73 |
| 2025-06-13 | 166.25 |
| 2025-06-12 | 171.06 |
| 2025-06-11 | 143.40 |
| 2025-06-10 | 143.40 |
| 2025-06-09 | 142.50 |
| 2025-06-06 | 136.78 |
| 2025-06-05 | 136.18 |
| 2025-06-04 | 138.89 |
| 2025-06-03 | 134.68 |
| 2025-06-02 | 132.28 |
| 2025-05-30 | 133.78 |
| 2025-05-29 | 132.88 |
| 2025-05-28 | 125.96 |
| 2025-05-27 | 127.77 |
| 2025-05-26 | 122.05 |
| 2025-05-23 | 125.66 |
| 2025-05-22 | 126.56 |
| 2025-05-21 | 125.96 |
| 2025-05-20 | 125.66 |
| 2025-05-19 | 122.05 |
| 2025-05-16 | 121.75 |
| 2025-05-15 | 117.24 |
| 2025-05-14 | 120.25 |
| 2025-05-13 | 115.44 |
| 2025-05-12 | 115.44 |
| 2025-05-09 | 117.54 |
| 2025-05-08 | 116.64 |
| 2025-05-07 | 115.14 |
| 2025-05-06 | 118.75 |
| 2025-05-02 | 119.35 |
| 2025-04-30 | 117.54 |
| 2025-04-29 | 116.94 |
| 2025-04-28 | 115.44 |
| 2025-04-25 | 118.75 |
| 2025-04-24 | 116.94 |
| 2025-04-23 | 115.44 |
| 2025-04-22 | 115.14 |
| 2025-04-17 | 110.33 |
| 2025-04-16 | 108.53 |
| 2025-04-15 | 111.83 |
| 2025-04-14 | 112.43 |
| 2025-04-11 | 107.62 |
| 2025-04-10 | 103.42 |
| 2025-04-09 | 102.21 |
| 2025-04-08 | 102.81 |
| 2025-04-07 | 100.41 |
| 2025-04-03 | 116.94 |
| 2025-04-02 | 118.75 |
| 2025-04-01 | 116.04 |